NASH

An image of a person is shown with attention drawn to fat accumulated in his liver, a feature of the liver disease non-alcoholic steatohepatitis (NASH). Next to the person is a blue circle with an image of a liver with kisspeptin hormone receptors depicted on the surface of the liver and arrows pointing downward to indicate a decrease in fatty liver and NASH.

Aug 19, 2022|3 min read

A sex hormone may help reverse liver damage

Scientists found that the Kisspeptin hormone activates enzymes that stop lipid formation in the mouse liver, suggesting that it has potential as a drug target for treating non-alcoholic fatty liver disease.

An ultrasound image of a liver is shown.

May 13, 2022|13 min read

By Stephanie DeMarco, PhD

Goodbye biopsies, non-invasive diagnostics for fatty liver disease are here

Through academic, industry, and governmental partnerships, scientists validate and develop non-invasive diagnostics for non-alcoholic fatty liver disease. These tests are set to replace the invasive and risky gold standard: liver biopsy.